Prostate Cancer clinical trials in Vermont

2 actively recruiting prostate cancer trials at 3 sites across Vermont.

Data from ClinicalTrials.gov · last refreshed 2026-07-07

Phase 3 Recruiting Network

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs? This study would like to find out if this approach is better o…

Sponsor: Canadian Cancer Trials Group

NCT ID: NCT06592924

Sites in Vermont:

Dartmouth Cancer Center - North — Saint Johnsbury, Vermont

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the…

Sponsor: SWOG Cancer Research Network

NCT ID: NCT03678025

Sites in Vermont:

Central Vermont Medical Center/National Life Cancer Treatment — Berlin Corners, Vermont
University of Vermont Medical Center — Burlington, Vermont

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-07-07